Brief: Motus GI Announces Positive Clinical Data For Pure-Vu EVS In Three Poster Presentations
24/10/2022 13:53
Oct 24 (Reuters) - Motus GI Holdings Inc MOTS.O :
* MOTUS GI ANNOUNCES POSITIVE CLINICAL DATA FOR PURE-VU EVS
IN
THREE POSTER PRESENTATIONS AT THE AMERICAN COLLEGE OF
GASTROENTEROLOGY (ACG) 2022 ANNUAL SCIENTIFIC MEETING
Source text for Eikon: ID:nGNXb5K0M9
Further company coverage: MOTS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Motus GI Holdings
See all newsBrief: Motus GI Holdings Inc Continuing To Explore A Range Of Strategic And Financing Alternatives
Brief: Motus Gi Holdings Files Prospectus Related To Resale Of Up To 4.4 Million Shares Of Common Stock, By The Selling Stockholder
Brief: Motus GI Granted A U.S. Patent For Key Feature Embodied By The Pure-Vu System
U.S. STOCKS ON THE MOVE-Chewy, Amgen, Bluebird bio
Brief: Motus Gi Holdings Says Prices Public Offering At $1.50 Per Share